Related Experiment Video
Updated: May 7, 2026

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
Role of SPARC in bone remodeling and cancer-related bone metastasis
Nilza Ribeiro1, Susana R Sousa, Rolf A Brekken
1INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Rua do Campo Alegre, 823, 4150-180, Porto, Portugal; Departamento de Engenharia Metalúrgica e de Materiais, Faculdade de Engenharia (FEUP), Universidade do Porto, Rua Roberto Frias, s/n, 4200-465, Porto, Portugal.
Abstract:
There is a growing socioeconomic recognition that clinical bone diseases such as bone infections, bone tumors and osteoporotic bone loss mainly associated with ageing, are major issues in today's society. SPARC (secreted protein, acidic and rich in cysteine), a matricellular glycoprotein, may be a promising therapeutic target for preventing or treating bone-related diseases. In fact, SPARC is associated with tissue remodeling, repair, development, cell turnover, bone mineralization and may also participate in growth and progression of tumors, namely cancer-related bone metastasis. Yet, the function of SPARC in such biological processes is poorly understood and controversial. The main objective of this work is to review the current knowledge related to the activity of SPARC in bone remodeling, tumorigenesis, and bone metastasis. Progress in understanding SPARC biology may provide novel strategies for bone regeneration and the development of anti-angiogenic, anti-proliferative, or counter-adhesive treatments specifically against bone metastasis.
Insights
Secreted protein acidic rich in cysteine (SPARC) is a potential target for bone diseases like osteoporosis and cancer metastasis. Further research into SPARC
Area of Science:
- Biochemistry
- Oncology
- Orthopedics
Background:
- Bone diseases including infections, tumors, and osteoporosis are significant socioeconomic concerns.
- Secreted protein acidic rich in cysteine (SPARC), a matricellular glycoprotein, is implicated in bone remodeling, mineralization, and tumor progression.
- The precise role of SPARC in these processes remains poorly understood and debated.
Purpose of the Study:
- To review current knowledge on SPARC's activity in bone remodeling, tumorigenesis, and bone metastasis.
- To highlight SPARC's potential as a therapeutic target for bone-related conditions.
Main Methods:
- Literature review of existing research on SPARC and bone biology.
- Analysis of SPARC's involvement in tissue remodeling, cell turnover, and mineralization.
- Examination of SPARC's role in primary bone tumors and cancer-related bone metastasis.
Main Results:
- SPARC is associated with various aspects of bone biology, including development, repair, and mineralization.
- SPARC's function in bone tumorigenesis and metastasis is complex and requires further elucidation.
- Contradictory findings exist regarding SPARC's specific effects in different bone contexts.
Conclusions:
- Understanding SPARC's multifaceted roles is crucial for developing effective therapeutic strategies.
- SPARC presents a promising target for novel treatments aimed at bone regeneration and combating bone metastasis.
- Future research should focus on clarifying SPARC's mechanisms to enable targeted anti-cancer and bone-healing therapies.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling and Repair
Bone Remodeling
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

